Sunshine Biopharma Inc (SBFM): SBFM has 51 drugs on the market Presc...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Sunshine Biopharma Inc (SBFM)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	21
Posts	2068
Boards Moderated	8
Alias Born	08/14/2021

Re: Jaxxm post# 113263

Tuesday, 03/05/2024 11:07:15 PM

Tuesday, March 05, 2024 11:07:15 PM

SBFM has 51 drugs on the market

Prescription drugs
Our generic prescriptions drugs are sold through Nora Pharma Inc., our wholly-owned Canadian subsidiary.

NAME

ACTION/INDICATION

REFERENCE BRAND

Alendronate

Osteoporosis

Fosamax®

Amlodipine

Cardiovascular

Norvasc®

Apixaban

Cardiovascular

Eliquis®

Atorvastatin

Cardiovascular

Lipitor®

Azithromycin

Antibacterial

Zithromax®

Candesartan

Hypertension

Atacand®

Candesartan HCTZ

Hypertension

Atacand®

Celecoxib

Anti-inflammatory

Celebrex®

Cetirizine

Allergy

Reactine®

Ciprofloxacin

Antibiotic

Cipro®

Citalopram

Central nervous system

Celexa®

Clindamycin

Antibiotic

Dalacin®

Clopidogrel

Cardiovascular

Plavix®

Donepezil

Central nervous system

Aricept®

Duloxetine

Central nervous system

Cymbalta®

Dutasteride

Urology

Avodart®

Escitalopram

Central nervous system

Cipralex®

Ezetimibe

Cardiovascular

Ezetrol®

Finasteride

Urology

Proscar®

Flecainide

Cardiovascular

Tambocor®

Fluconazole

Antifungal

Diflucan®

Fluoxetine

Central nervous system

Prozac®

Hydroxychloroquine

Antimalarial

Plaquenil®

Lacosamide

Central nervous system

Vimpat®

Letrozole

Oncology

Femara®

Levetiracetam

Central nervous system

Keppra®

Mirtazapine

Central nervous system

Remeron®

Montelukast

Allergy

Singulair®

Olanzapine ODT

Central nervous system

Zyprexa®

Olmesartan

Cardiovascular

Olmetec®

Olmesartan HCTZ

Cardiovascular Olmetec

Plus®

Pantoprazole

Acid Reflux

Pantoloc®

Paroxetine

Central nervous system

Paxil®

Perindopril

Cardiovascular

Coversyl®

Pravastatin

Cardiovascular

Pravachol®

Pregabalin

Central nervous system

Lyrica®

Quetiapine

Central nervous system

Seroquel®

Quetiapine XR

Central nervous system

Seroquel XR®

Ramipril

Cardiovascular

Altace®

Rizatriptan ODT

Central nervous system

Maxalt® ODT

Rosuvastatin

Cardiovascular

Crestor®

Sertraline

Central nervous system

Zoloft®

Sildenafil

Urology

Viagra®

Tadalafil

Urology

Cialis®

Telmisartan

Cardiovascular

Micardis®

Telmisartan HCTZ

Cardiovascular

Micardis Plus®

Tramadol Acetaminophen

Central nervous system

Tramacet®

Zolmitriptan

Central nervous system

Zomig®

Zopiclone

Central nervous system

Imovane®

HEADQUARTERS

1177 Avenue of the Americas, 5 th Floor
New York, NY 10036
USA
Tel: 332-216-1147

MONTREAL OFFICE
6500 Trans-Canada Highway, 4th Floor
Pointe-Claire, Quebec H9R 0A5
CANADA
Tel: 514-426-6161

info@sunshinebiopharma.com

© 2023 SUNSHINE BIOPHARMA INC.

All rights reserved.

https://sunshinebiopharma.com/prescription-drugs/

Bullish

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent SBFM News

Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:05:31 PM
Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 03/05/2024 09:37:03 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:05:35 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/23/2024 09:03:01 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/21/2024 09:28:39 PM
Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 02/21/2024 01:24:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:01:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 04:39:32 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:53:03 PM
Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/14/2024 04:18:31 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/13/2024 05:15:10 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 09:05:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 02:04:50 PM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 10:17:56 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/01/2024 09:17:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 05:38:24 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/08/2024 01:10:54 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:59:51 PM
Sunshine Biopharma Moves Principal Office to New York City • GlobeNewswire Inc. • 12/04/2023 01:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 02:00:15 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:00:46 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 04:18:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 05:06:33 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/19/2023 04:10:36 PM

More SBFM News

InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow